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This work is focused on pyrazine derivatives with the structural relationship to 
pyrazinamide (PZA) and with the potential antitubercular effect. In the introduction, 
there are summarized theoretical findings about tuberculosis (TBC), its epidemiology 
and primarily the development of resistance to current pharmacotherapy. Brief 
overview of known antituberculars, novel compounds and auspicious molecules in 
clinical trials is outlined. PZA, which is counted among the first line antitubercular 
agents, is widely described due to its cardinal role in this thesis. PZA possible 
mechanisms of action are described together with its pharmacological profile. Finally, 
brief summary of already prepared derivatives of PZA is stated. 
Practical part of this thesis is focused on synthesis of three starting compounds 
(5-chloro-6-methylpyrazine-2,3-dicarbonitrile; 3-chloropyrazine-2-carboxamide; 
N-benzyl-3-chloropyrazine-2-carboxamide) that were substituted by 
aminodehalogenation reaction using microwave reactor. There were 79 compounds of 
which 75 were novel and not described in literature. Aminodehalogenation was 
accomplished by addition of aromatic amines, benzylamines, aromatic 
phenylhydrazines, and aliphatic or alicyclic amines. Prepared compounds were in vitro 
evaluated for their antimycobacterial activity against Mycobacterium tuberculosis 
H37Rv, M. kansasii, M. avium a M. smegmatis. Some derivatives from prepared series 
demonstrated activity against M. tuberculosis comparable to or better than standard 
PZA (MIC ranging between 6 and 24 µM). The most auspicious compounds activities 
were approximating to the activity of isoniazid. Derivatives active against other 
mycobacterial species were identified. The structure-activity relationships were 
discussed. Most of compounds were additionally tested for their antibacterial, 
antifungal, antiviral, and herbicidal activities finding compounds showing remarkable 
results especially in connection with antimycotic efficacy. 
The results of this thesis are following the long-standing research intention of the 
Pharmaceutical chemistry and Pharmaceutical analysis department, Faculty of 
Pharmacy, Charles University. Mainly, it is connected with research group of prof. 
PharmDr. Martin Doležal, Ph.D. that is dealing with the study of novel potentially 
active antitubercular agents derived from PZA. 
 
